Global Sialorrhea Treatment Market is segmented By Treatment Type (Botulinum Toxin Injections (Xeomi...
Market Size in USD Mn
CAGR5.5%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 5.5% |
Market Concentration | High |
Major Players | Merz Pharmaceuticals, US WorldMeds, NeuroHealing, Proveca, Eisai (via Sloan Pharma) and Among Others |
The sialorrhea treatment market is estimated to be valued at USD 813.4 Mn in 2025 and is expected to reach USD 1183.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032. The increasing prevalence of neurological diseases such as Parkinson's disease, amyotrophic lateral sclerosis and cerebral palsy is expected to drive the growth of this market during the forecast period.